CD44 and breast carcinoma: In view of the reported involvement of IGF-1R signaling in the metastasis [24,25] and epithelial-mesenchymal transition (EMT) [26] of breast cancer cells, we further investigated whether IGF-1R signal also regulates EMT process in CD44+ BCSCs.